Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-arm, Double-blind, Randomized, Placebo-controlled Trial Investigating the Efficacy of the Probiotic Dietary Supplement SmartProbio C in the Supportive Supplementation of Patients With a Complicated Course of COVID-19 Infection

NCT05474144 is registered in ClinicalTrials.gov with Medi Pharma Vision as lead sponsor.

NCT NCT05474144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05474144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-arm, Double-blind, Randomized, Placebo-controlled Trial Investigating the Efficacy of the Probiotic Dietary Supplement SmartProbio C in the Supportive Supplementation of Patients With a Complicated Course of COVID-19 Infection
Lead sponsor
Medi Pharma Vision
Phase
Not applicable
Overall status
Completed
Start date
November 12, 2021
Completion date
April 30, 2022
Enrollment
83 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19